Literature DB >> 8699639

Selective inhibition of inducible nitric oxide synthase by agmatine.

M Auguet1, I Viossat, J G Marin, P E Chabrier.   

Abstract

Agmatine was about as potent as aminoguanidine to inhibit the activity of the inducible form of nitric oxide synthase (iNOS) in isolated rat aorta. Like aminoguanidine, agmatine was devoid of significant activity on the constitutive form of NOS. Agmatine inhibited the conversion of [3H]L-arginine in [3H]L-citrulline in partially purified iNOS from macrophages (IC50 = 262 +/- 39.9 microM). Thus, our data suggest that agmatine may act as endogenous inhibitor of iNOS.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8699639     DOI: 10.1254/jjp.69.285

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  27 in total

Review 1.  Biological significance of agmatine, an endogenous ligand at imidazoline binding sites.

Authors:  W Raasch; U Schäfer; J Chun; P Dominiak
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

2.  Potential relevance of agmatine as a virulence factor of Helicobacter pylori.

Authors:  G J Molderings; M Burian; J Homann; M Nilius; M Göthert
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

3.  Agmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats: involvement of neuropeptide Y.

Authors:  B G Taksande; N R Kotagale; K T Nakhate; P D Mali; D M Kokare; K Hirani; N K Subhedar; C T Chopde; R R Ugale
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

4.  Neurochemical evidence for agmatine modulation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity.

Authors:  Gad M Gilad; Varda H Gilad; John P M Finberg; Jose M Rabey
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

5.  Agmatine attenuates brain edema through reducing the expression of aquaporin-1 after cerebral ischemia.

Authors:  Jae Hwan Kim; Yong Woo Lee; Kyung Ah Park; Won Taek Lee; Jong Eun Lee
Journal:  J Cereb Blood Flow Metab       Date:  2009-12-23       Impact factor: 6.200

6.  Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury.

Authors:  C A Fairbanks; K L Schreiber; K L Brewer; C G Yu; L S Stone; K F Kitto; H O Nguyen; B M Grocholski; D W Shoeman; L J Kehl; S Regunathan; D J Reis; R P Yezierski; G L Wilcox
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

7.  Beneficial effect of agmatine on brain apoptosis, astrogliosis, and edema after rat transient cerebral ischemia.

Authors:  Che-Chuan Wang; Chung-Ching Chio; Ching-Hong Chang; Jinn-Rung Kuo; Ching-Ping Chang
Journal:  BMC Pharmacol       Date:  2010-09-06

Review 8.  Agmatine : metabolic pathway and spectrum of activity in brain.

Authors:  Angelos Halaris; John Plietz
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

9.  Supraspinally-administered agmatine attenuates the development of oral fentanyl self-administration.

Authors:  Carrie L Wade; Daniel J Schuster; Kristine M Domingo; Kelley F Kitto; Carolyn A Fairbanks
Journal:  Eur J Pharmacol       Date:  2008-04-08       Impact factor: 4.432

10.  Protective effects of agmatine against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure in mice.

Authors:  Dina S El-Agamy; Mirhan N Makled; Nareman M Gamil
Journal:  Inflammopharmacology       Date:  2013-08-30       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.